COMBOGESIC IV
Active substance: ACETAMINOPHEN, IBUPROFEN
INJECTION · ACETAMINOPHEN 1000 mg/100mL, IBUPROFEN 300 mg/100mL
United StatesActive
Marketing holder: Hikma Pharmaceuticals USA Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- ACETAMINOPHEN · 1000 mg/100mL
- IBUPROFEN · 300 mg/100mL
Registration
- Registration number
- 0143-9150
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 0143-9150 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0143-9150 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0143-9150 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 0143-9150 · Verified 2026-10-09 · open in source